Trial Details

COMPLETED
Basic Information
Clinical ID c2050
Identifier NCT04053790
Trial Title Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome With Diarrhea
Interventions DRUG: lactobacillus LB|OTHER: placebo
Participant Information
Sponsor Hospital General de Mexico
City Choose Any State/Province
Country/Region Mexico
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2019-01-15
Primary Completion Date 2023-01-29
Completion Date 2023-01-29